FDA Reorganization To Focus On Employee Specialization
This article was originally published in The Pink Sheet Daily
Agency’s Program Alignment Group recommends “commodity-based and vertically-integrated programs” to improve efficiency and communication.
You may also be interested in...
FDA’s broad reorganization may not create the same super-specialization for the import staff that is coming to other parts of the agency, but a process overhaul appears on its way regardless.
Agency restructures staff as it prepares for new U.S.-EU mutual reliance activities to enhance pharmaceutical quality but offers few details on upcoming plans.
Steve Lynn, director of CDER’s Office of Manufacturing and Product Quality, will take an executive global compliance position.